Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.

@article{Hajak2001DoxepinIT,
  title={Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.},
  author={Goeran Hajak and Andrea Rodenbeck and Ulrich Voderholzer and Dieter Riemann and Stefan Cohrs and Fritz Hohagen and Mathias Berger and Eckart Ruether},
  journal={The Journal of clinical psychiatry},
  year={2001},
  volume={62 6},
  pages={453-63}
}
BACKGROUND Over recent years, the use of antidepressants for the symptomatic treatment of insomnia has grown substantially, but controlled studies are still lacking. Our study is the first investigation to prove objective efficacy and tolerability of low doses of a sedating antidepressant in a randomized, double-blind, and placebo-controlled manner in patients with primary insomnia. METHOD Forty-seven drug-free patients meeting DSM-IV criteria for primary insomnia (mean +/- SD duration of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 40 extracted citations

Similar Papers

Loading similar papers…